Methyl-ß-orcinolcarboxylate from lichen (everniasrum cirrhatum) for use for the treatment of fungal infections and cancer

摘要

The present invention relates to the new use of an already known biomolecule methyl- b -orcinol carboxylate of formula (I) isolated from a lichen (Everniastrum cirrhatum), for treating pathogenic fungal infections of humans that are resistant to polyene and azole antibiotics such as amphotericin B, nystatin, clotrimazole etc.